Navigation Links
Cardiogenesis Enrolls First Two Patients in Its Feasibility Study of the PHOENIX® Combination Delivery System
Date:10/12/2010

IRVINE, Calif., Oct. 12 /PRNewswire/ -- Cardiogenesis Corporation (OTCQB: CGCP), a leading developer of surgical products used in the treatment of diffuse coronary artery disease, reported the enrollment of the first two patients in its PHOENIX Feasibility Study.  Dr. Guillermo Reyes at La Princesa Hospital, Madrid, Spain performed the procedures utilizing the company's proprietary PHOENIX System that combines the intramyocardial delivery of stem cells with transmyocardial revascularization (TMR).

"Myocardial stimulation via TMR has been proven to reduce angina for the majority of treated patients.  The synergy of the injection of autologous stem cells may provide greater angina reduction, and improve cardiac function in patients with diffuse disease who are not candidates for surgical bypass or intervention," commented Dr. Reyes.  "Survival rates have significantly improved for persons with coronary artery disease; however as this population lives longer they can outlive the effectiveness of their prior therapy.  Clinicians are faced with an expanding population of symptomatic patients with no option for conventional treatments.  Stem cell therapy with the Cardiogenesis technology has great promise as a solution for this growing clinical problem."

The two procedures were performed during an investigator meeting in Madrid, Spain on October 7-8.  Leading researchers at five medical centers from France, India, Italy, Russia, and Spain will participate in the study.  The company plans to begin clinical cases at those centers in the upcoming weeks.

"This is a significant milestone.  We will provide the early results of this feasibility study along with the pre-clinical testing being conducted at the Stem Cell Center of the Texas Heart Institute, to support our request to begin a multi-center IDE pivotal trial in the U.S. for the PHOENIX System," said Cardiogenesis Executive Chairman Paul McCormick.  "W
'/>"/>

SOURCE Cardiogenesis Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cardiogenesis Executive Chairman Paul J. McCormick Updates Commercial and Regulatory Progress in Interview With Wall Street Reporter, Available Online
2. Cardiogenesis Corporation to Report 2010 Second Quarter Results on August 4th
3. Cardiogenesis (CGCP) Listing Upgraded to New OTCQB(TM) Market for All U.S. Registered and Reporting OTC Securities
4. Cardiogenesis Corporation to Present at Noble Financial - ONTRACK 2010
5. Cardiogenesis Reports Third Quarter 2009 Results
6. Cardiogenesis Announces Presentation of its PHOENIX(R) Combination TMR Plus Stem Cell Delivery System at the International Society of Minimally Invasive Cardiothoracic Surgeons (ISMICS) Annual Meeting
7. Cardiogenesis Announces Preliminary Clinical Results With the PHOENIX System Combining TMR + Stem Cells
8. Omeros Enrolls First Patient in Phase 2b Clinical Trial Evaluating OMS302 in Patients Undergoing Cataract Surgery
9. BHR Pharma Enrolls First Patient in Phase 3 SyNAPSe Traumatic Brain Injury Trial
10. Crux Biomedical Enrolls First Patient in Its Retrieve 2 U.S. Pivotal Trial
11. Ophthotech Enrolls Its First Patient in a Randomized, Controlled Phase II Study of E10030 in Macular Degeneration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Nov. 21, 2014 In September 2014, the ... carried out a new product development plan that started ... "limited edition" lab coat , aptly named "Vera ... surgery in the world. The new women,s designer lab ... with a sleek envelope collar, vertical princess and high ...
(Date:11/21/2014)...  World Hemp Oil, an importer of oil extracted ... now offering legal, organic oil with high CBD (cannabidiol) ... in medical marijuana states. People suffering from epileptic seizures ... MS, and spinal cord injury, no longer have to ... CBD Oil Is legal in all states. ...
(Date:11/21/2014)... CITY, Calif. , Nov. 21, 2014  Abaxis, ... company manufacturing point-of-care instruments and consumables for the medical, ... services to the veterinary and research markets in ... completion of a stock purchase agreement to acquire 100% ... United Kingdom based distribution organization. The transaction ...
Breaking Medicine Technology:Medelita Introduces Medical Industry's First Limited Edition Women's Designer Lab Coat 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3Abaxis Acquires UK-based Distribution Organization 2Abaxis Acquires UK-based Distribution Organization 3Abaxis Acquires UK-based Distribution Organization 4
... Mass., May 16 BioVex Inc, a biotechnology,company ... announced today that the abstract describing the interim ... GM-CSF in advanced metastatic,melanoma is now available at ... at http://www.asco.org . A summary of the ...
... a Small Molecule with ... Demonstrated Therapeutic Activity, SAN CARLOS, Calif., May ... today from a Phase 1,study of NKTR- 102, PEGylated irinotecan. ... tumors. The study,also demonstrates that Nektar,s small molecule PEGylation technology,produced ...
Cached Medicine Technology:BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 2BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 3Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 2Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 3Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 4Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 5
(Date:11/22/2014)... Discount-Dress.com is an important company in the dress industry. ... company’s online market share by a series of promotions. Recently, ... announced a bridesmaid dress promotion for the new year 2015. ... the dresses from this company are not only of high ... very good at manufacturing wedding dresses. Customers prefer to choose ...
(Date:11/22/2014)... Dallas, TX (PRWEB) November 22, 2014 ... Society (ICS) as the complaint that the individual ... times for voiding. The report “Nocturia – Pipeline ... therapeutic development for Nocturia, complete with comparative analysis ... mechanism of action (MoA), route of administration (RoA) ...
(Date:11/22/2014)... A petition seeking a ban on ... in minimally-invasive hysterectomies and fibroid removal surgeries has gained ... October, Bernstein Liebhard LLP reports. According to Change.org, ... 21st, 2014. That represents an increase of 456 signatures ... to the campaign.* , The campaign to ban uterine ...
(Date:11/22/2014)... (HealthDay News) -- The wide variety and complexity of ... for people with food allergies, an expert warns. ... types of food allergies that it can be really ... Guha Krishnaswamy, director of allergy and clinical immunology at ... news release. "If you know you have food ...
(Date:11/22/2014)... Lipitor lawsuits ( http://www.lipitorlawsuitcenter.com/ ) that ... developed Type 2 diabetes due to its use continue ... underway in U.S. District Court, District of South Carolina, ... litigation will convene its next Status Conference on December ... Counsel for Plaintiffs and Defendants to meet and confer, ...
Breaking Medicine News(10 mins):Health News:Bridesmaid Dresses Introduced by Famous Company Discount-Dress.com For The New Year 2015 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 3Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 4Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 4Health News:'Tis the Season of Challenges for Those With Food Allergies 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 3
... inherited condition resulting in blindness and crumbling teeth have ... function and normal tooth development. , A ... teeth and eyes has been uncovered by researchers from ... living in a village in the war-torn Gaza strip. ...
... 12 The Terri Lynne Lokoff Child Care Foundation ... Lokoff/Children,s TYLENOL(R) National Child Care Teacher Awards(TM). Fifty ... across the United States and on U.S. Military bases ... commitment to maintaining high-quality child care practices and dedication ...
... After injuries with blood loss, the body quickly needs to ... special group of stem cells in the bone marrow. These ... only awakened to activity in case of injury and loss ... for the loss of blood cells. This has recently been ...
... Calif., Feb. 12 Evalve, Inc., the leader ... of cardiac valves,announced today that the first series ... system at the St. Antonius Hospital, Nieuwegein,Utrecht, Netherlands. ... available in the European Union which provides a ...
... Expert Intensives, Welcomes New Staff, and Launches Special Value ... Miraval Tucson, the top-rated resort and spa dedicated ... off 2009 with the introduction of cutting-edge programs and ... The resort also is offering value packages this winter, ...
... Industry Veteran Joins Leading Healthcare IT Consulting FirmWESTFIELD, ... announced David H. Tucker as National Accounts Business ... company for healthcare providers, is pleased to confirm ... business development for the firm. Before joining ...
Cached Medicine News:Health News:Gaza strip families give first clue to condition causing blindness and tooth decay 2Health News:Terri Lynne Lokoff Child Care Foundation Announces Recipients of the 2009 Terri Lynne Lokoff/Children's TYLENOL(R) National Child Care Teacher Awards(TM) 2Health News:Stem cells: Deathly awakening by interferon 2Health News:First Dutch Patients Treated With the Percutaneous MitraClip(R) System 2Health News:First Dutch Patients Treated With the Percutaneous MitraClip(R) System 3Health News:Miraval Tucson Introduces New Programming for 2009 2Health News:Miraval Tucson Introduces New Programming for 2009 3Health News:Miraval Tucson Introduces New Programming for 2009 4Health News:maxIT Healthcare Names David H. Tucker as National Accounts Business Director 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: